Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer

PURPOSE: Although most breast cancer patients who receive neoadjuvant chemotherapy (NCT) have a tumor response, a small proportion experience progressive disease (PD). Predictors of response have been reported, but predictors for progression have not been identified. We sought to identify predictors...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Caudle, Abigail S., Gonzalez-Angulo, Ana M., Hunt, Kelly K., Liu, Ping, Pusztai, Lajos, Symmans, W. Fraser, Kuerer, Henry M., Mittendorf, Elizabeth A., Hortobagyi, Gabriel N., Meric-Bernstam, Funda
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2010
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2860366/
https://ncbi.nlm.nih.gov/pubmed/20231683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.3286
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars